Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gain Therapeutics Inc
(NQ:
GANX
)
0.9814
+0.0144 (+1.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Gain Therapeutics Inc
< Previous
1
2
3
4
5
Next >
GANX Stock Earnings: Gain Therapeutics Misses EPS for Q2 2024
August 08, 2024
GANX stock results show that Gain Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Gain Therapeutics Reports Financial Results for Second Quarter 2024 and Provides Corporate Update
August 08, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Gain Therapeutics to Participate at BTIG Virtual Biotechnology Conference
August 01, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
7 Sorry Biotech Stocks Set to Make Investors Sad
July 22, 2024
Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
July 04, 2024
Via
Benzinga
Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024
June 28, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 28, 2024
Pre-market stock movers are a hot topic on Friday and we're breaking down all of the latest news sending shares higher and lower!
Via
InvestorPlace
Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
June 27, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) Forum 2024 Demonstrating Improvements in Cognitive Performance in a Preclinical Model of GBA1 Parkinson’s disease
June 27, 2024
Data demonstrates improvement in cognitive function in GBA1 Parkinson’s disease model in addition to reversal of motor function deficits
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Gain Therapeutics to Participate at H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
June 25, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
InvestorNewsBreaks – Gain Therapeutics Inc. (NASDAQ: GANX) Releases Pricing of Underwritten Public Offering, Projected to Reach $11M
June 18, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
S&P 500 Edges Lower; RH Shares Plunge After Q1 Results
June 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
June 14, 2024
Via
Benzinga
Gold Gains 1%; US Consumer Sentiment Falls In June
June 14, 2024
Via
Benzinga
Dear ARM Stock Fans, Mark Your Calendars for June 24
June 14, 2024
Arm stock is up on Friday and is preparing for a catalyst later this month when it replaces Sirius XM on the Nasdaq 100.
Via
InvestorPlace
Dow Tumbles Over 200 Points; Adobe Earnings Top Views
June 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is Gain Therapeutics (GANX) Stock Down 25% Today?
June 14, 2024
Gain Therapeutics stock is down on Friday after the company priced an $11 million public offering for roughly 7 million shares of GANX.
Via
InvestorPlace
Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
June 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
June 14, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
June 14, 2024
Pre-market stock movers are worth checking out on Friday as we dive into all of the biggest news moving shares this morning!
Via
InvestorPlace
Gain Therapeutics Announces Pricing of $11.0 Million Public Offering
June 13, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Gain Therapeutics Announces Proposed Public Offering
June 13, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 30, 2024
Via
Benzinga
Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federation of European Neuroscience Societies (FENS) Forum 2024
May 30, 2024
New data demonstrating improvement of cognitive performance after treatment with GT-02287 in preclinical model of GBA1 Parkinson’s disease
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
GANX Stock Earnings: Gain Therapeutics Beats EPS for Q1 2024
May 14, 2024
GANX stock results show that Gain Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
May 14, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease
April 24, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer
April 08, 2024
From
Gain Therapeutics, Inc.
Via
GlobeNewswire
Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
April 02, 2024
The Dow Jones index closed lower by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit